Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Archimed acquires Deallus Consulting

Archimed acquires Deallus Consulting

15th December 2015

Archimed has acquired a majority controlling stake in Deallus Consulting, a global life sciences consultancy.

The independent private equity healthcare specialist will be purchasing Deallus in order to increase its involvement in pharmaceutical services, while it is reviewing a number of possible bolt-on acquisitions.

Headquartered in London, Deallus has a staff of 80 consultants, with offices in New York, Los Angeles, Princeton, Tokyo and Singapore. Its annual revenue growth has averaged around 20 percent since being established in 2004.

Turnover in the consultancy's most recent fiscal year came to 15 million pounds, making it a potentially valuable asset.

Robin Filmer-Wilson, a managing partner of ArchiMed, said: "We intend to accelerate the growth of Deallus by providing access to new accounts, aiding recruitment and helping to set up additional offices globally."

ArchiMed is a financial and strategic partner for European healthcare companies, founded in 2014 by former 3i Healthcare Team members who have successfully invested more than 500 million euros (364.6 million pounds) in this sector over the past 15 years.ADNFCR-8000103-ID-801808130-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.